Bivalent rotavirus VP4∗ stimulates protective antibodies against common genotypes of human rotaviruses
Summary: Non-replicating rotavirus vaccines are an alternative strategy to improve the efficacy and safety of rotavirus vaccines. The spike protein VP4, which could be enzymatically cleaved into VP8∗ and VP5∗, is an ideal target for the development of recombinant rotavirus vaccine. In our previous s...
Main Authors: | Guoxing Luo, Yuanjun Zeng, Han Yang, Yijian Li, Lianwei Yang, Cao Li, Feibo Song, Shiyin Zhang, Tingdong Li, Shengxiang Ge, Jun Zhang, Ningshao Xia |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-10-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004222013712 |
Similar Items
-
Genotypic determination of human group A rotaviruses from Goa and Meghalaya states, India
by: Abhay Raorane, et al.
Published: (2020-08-01) -
Molecular evolution of the capsid (VP1) region in human norovirus genogroup II genotype 3
by: Mariko Saito, et al.
Published: (2020-05-01) -
Bacterial resistance to temperate phage is influenced by the frequency of lysogenic establishment
by: Hiba Baaziz, et al.
Published: (2024-04-01) -
Establishment of Sandwich ELISA for Quality Control in Rotavirus Vaccine Production
by: Cao Li, et al.
Published: (2022-02-01) -
A high-throughput liquid bead array assay confirms strong correlation between SARS-CoV-2 antibody level and COVID-19 severity
by: Monique Bennett, et al.
Published: (2021-02-01)